Simplifying Global Compliance
Deadline Set for Generic-Drug Makers to Withdraw Pending ANDAs or Pay Fee
Washington Drug Letter
Generic drugmakers have until Sept. 28 to either withdraw pending ANDAs or face a backlog fee, the FDA says.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing